Wave Life Sciences Ltd. (WVE) Discusses Positive Interim Phase I Data from INLIGHT Trial of WVE-007 for Obesity Transcript
Wave Life Sciences Ltd. (WVE) Discusses Positive Interim Phase I Data from INLIGHT Trial of WVE-007 for Obesity - Slideshow (NASDAQ:WVE) 2026-03-26
Clear Street riduce il target di prezzo di Wave Life Sciences per le prospettive del mercato dell’obesità